Koss-Olinger Consulting’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
58,648
-587
-1% -$18.5K 0.15% 57
2025
Q4
$1.75M Sell
59,235
-18,550
-24% -$515K 0.14% 61
2025
Q3
$1.87M Sell
77,785
-93
-0.1% -$2.27K 0.15% 81
2025
Q2
$1.87M Sell
77,878
-1,711
-2% -$39.7K 0.15% 81
2025
Q1
$1.82M Buy
79,589
+55,896
+236% +$1.35M 0.15% 79
2024
Q4
$600K Buy
+23,693
New +$600K 0.05% 113

Other funds holding RTO

Koss-Olinger Consulting's RTO Position: Q1 2026 in Review

Koss-Olinger Consulting reduced its Rentokil (RTO) stake by 0.99% in Q1 2026, selling an estimated $18.5K and leaving 58,648 shares worth $1.85M. The position accounts for 0.15% of the portfolio, ranked #57.

Koss-Olinger Consulting first reported a position in RTO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.87M in Q2 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Koss-Olinger Consulting held 58,648 shares of Rentokil worth $1.85M as of Q1 2026.
  • Koss-Olinger Consulting sold 587 Rentokil shares in Q1 2026, an estimated $18.5K.
  • Rentokil made up 0.15% of Koss-Olinger Consulting's portfolio in Q1 2026, its #57 holding.
  • Koss-Olinger Consulting first reported a position in Rentokil in Q4 2024 and has held it in 6 quarters since.
  • Koss-Olinger Consulting's Rentokil position peaked at $1.87M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.